U.S. Markets close in 5 hrs 48 mins
  • S&P 500

    -12.97 (-0.28%)
  • Dow 30

    -68.97 (-0.19%)
  • Nasdaq

    -76.64 (-0.49%)
  • Russell 2000

    -21.30 (-0.94%)
  • Crude Oil

    -0.80 (-1.11%)
  • Gold

    -9.00 (-0.50%)
  • Silver

    -0.49 (-2.17%)

    -0.0045 (-0.3955%)
  • 10-Yr Bond

    -0.0270 (-1.79%)
  • Vix

    +0.42 (+2.11%)

    -0.0003 (-0.0264%)

    -0.2130 (-0.1873%)

    -2,155.06 (-4.23%)
  • CMC Crypto 200

    -34.19 (-2.62%)
  • FTSE 100

    -23.22 (-0.32%)
  • Nikkei 225

    -135.15 (-0.47%)

Axxess Pharma Signs Agreement to Expand Full Tapout Line Into Over 60 High Profile Shopping Centers Across Canada by Early Summer

TORONTO, ON--(Marketwired - Apr 29, 2015) - Axxess Pharma Inc. (OTC PINK: AXXE), a specialty pharmaceutical and nutritional supplements company is pleased to announce that they have been approved by Canada's leading health product franchise, "Nutrition House" to sell its full line of Tapout products. The Tapout products will be available in over 60 high profile shopping centers across Canada by early summer.

Nutrition House determined Axxess Pharma's all-natural Tapout product line, including their high potency Omega 3 Fish Oil supplements and all-natural, gluten free, protein shakes are an excellent synergy for their health conscious customers. Nutrition House anticipates strong demand for the Tapout line, as more customers become aware of the all-natural Tapout products on their shelves.

Nutrition House is known through-out Canada for providing the highest grade of products to their customers. These products include national brands of vitamins, supplements, body care, sports nutrition products, as well as exclusive nutrition house extra products, and co-branded extra-value products, packaged exclusively for nutrition house by national brand suppliers. Nutrition House products can be purchased in their stores or online at http://www.nutritionhouse.com/

This agreement is part of Axxess Pharma's aggressive push to continue the expansion of their all-natural Tapout line into shopping centers, pharmacies and major brick and mortar retail supermarket chains across Canada and the United States. Axxess Pharma has also continued to expand globally through industry leading natural health distributors.

Dr. Bagi, President of Axxess Pharma Inc., stated: "We are honored to have our Tapout products on the shelves of Nutrition Health, the leading health product franchise in Canada. This agreement now expands our product line into high profile, high traffic shopping centers across Canada." Dr. Bagi further stated, "2015 has continued to be a strong year for our company, as we have increased our sales in Australia and received approval by a major Canadian distributor to sell Muscle Spray and Tapout Pain relief Towelettes to over 2,000 independent pharmacies across Canada."

About Axxess Pharma Inc.:
Axxess Pharma Inc. is a Nevada Corporation operating through its wholly-owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain, - to optimal health management through improved nutritional supplements.

About Authentic Brands Group, LLC
Authentic Brands Group, is a brand development, licensing, and entertainment company. In conjucntion with Leonard Green & Partners, ABG's mandate is to acquire, manage, and elevate long-term value in consumer, celebrity, and media brands. Headquartered in New York City, ABG's mission is to further enhance brand equity through partnering with best-in-class licensees and retailers. ABG's global portfolio of world-renowned brands includes Marilyn Monroe®, Mini Marilyn®, Muhammad Ali®, Elvis Presley®, Jones New York®, Juicy Couture®, Judith Leiber®, Adrienne Vittadini®, Taryn Rose®, Hickey Freeman®, Hart Schaffner Marx®, Palm Beach®, Misook®, Prince®, Spyder®, Airwalk®, Above The Rim®, Vision Street Wear®, Hind®, Ektelon®, Viking®, Bobby Jones®, Tapout®, Sportcraft®. www.abg-nyc.com.

For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.

Safe Harbor Statement:
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.